Picture Demy-Colton BioFuture 2023 NYC Hand 650x100px
Organisation › Details

Biogen Inc. (Nasdaq: BIIB)

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. *


Period Start 2015-03-23 renamed
  Group Biogen (Group)
  Predecessor Biogen Idec Inc. (Nasdaq: BIIB)
Product Industry BIOTECH
Region Region Cambridge, MA
  Country United States (USA)
  Street 225 Binney Street
  City 02142 Cambridge, MA
  Tel +1-781-464-2000
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for »About Section«: 
Record changed: 2023-08-24


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Biogen (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Consultech GmbH Secure Funding with RnD Grants 650x300px

» top